Tricuspid valve prolapse as an early predictor for severe phenotype in children with Marfan syndrome
- PMID: 35194851
- DOI: 10.1111/apa.16307
Tricuspid valve prolapse as an early predictor for severe phenotype in children with Marfan syndrome
Abstract
Aim: In Marfan syndrome, various cardiovascular pathologies, such as aortic dilatation and mitral valve pathologies, already occur in childhood and determine course of the disease. This study aimed to establish additional cardiovascular risk markers for severe Marfan phenotypes. We investigated tricuspid valve prolapse (TVP) and its predictive value for outcome of paediatric Marfan disease.
Methods: In this retrospective, observational cohort study, we identified 130 paediatric Marfan patients (10.7 ± 4.8 years) with FBN1 variants. We divided patients into two groups based on TVP presence and performed a cross-sectional analysis to investigate the association of TVP with other cardiovascular, ocular and systemic pathologies, at first and last visit. A longitudinal analysis was performed with follow-up data.
Results: At baseline, patients with TVP had higher incidence of aortic root dilatation (p = 0.013), mitral valve prolapse (p = 0.0001) and systemic manifestations (p = 0.025) than patients without TVP. At follow-up, previous presence of TVP predicted higher probability of aortic root dilatation (p = 0.002), mitral valve prolapse (p = 0.0001) and systemic manifestations (p = 0.002).
Conclusion: This shows that TVP is linked to both cardiac and extracardiac Marfan manifestations and TVP is an important marker for a disease severity in these children. Therefore, TVP should be assessed routinely using echocardiography in paediatric Marfan patients.
Keywords: Marfan syndrome; children; prognosis; tricuspid valve prolapse.
© 2022 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.
References
REFERENCES
-
- Groth KA, Hove H, Kyhl K, et al. Prevalence, incidence, and age at diagnosis in Marfan Syndrome. Orphanet J Rare Dis. 2015;10(1):153. doi:10.1186/s13023-015-0369-8
-
- Lipscomb KJ, Clayton-Smith J, Harris R. Evolving phenotype of Marfan’s syndrome. Arch Dis Child. 1997;76(1):41-46. doi:10.1136/adc.76.1.41
-
- Judge DP, Dietz HC. Marfan’s syndrome. Lancet. 2005;366(9501):1965-1976. doi:10.1016/S0140-6736(05)67789-6
-
- De Backer J, Campens L, Muiño ML. Looking for the missing links: Challenges in the search for genotype-phenotype correlation in Marfan syndrome. Circ Genom Precis Med. 2018;11(6): doi:10.1161/CIRCGEN.118.002185
-
- De Backer J, Loeys B, Devos D, Dietz H, De Sutter J, De Paepe A. A critical analysis of minor cardiovascular criteria in the diagnostic evaluation of patients with Marfan syndrome. Genet Med. 2006;8(7):401-408. doi:10.1097/01.gim.0000223550.41849.e3
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical